What is AbCellera Biologics Inc.'s compensation and benefits?

AbCellera Biologics Inc. (ABCL) reported compensation and benefits of $3.93M in Q1 2026.

How has AbCellera Biologics Inc.'s compensation and benefits changed year-over-year?

AbCellera Biologics Inc.'s compensation and benefits increased by 23.2% year-over-year, from $3.19M to $3.93M.

What is the long-term trend for AbCellera Biologics Inc.'s compensation and benefits?

Over 3 years (2022 to 2025), AbCellera Biologics Inc.'s compensation and benefits has grown at a 18.6% compound annual growth rate (CAGR), from $6.45M to $10.76M.

AbCellera Biologics Inc. ABCL Compensation and benefits

Compensation and benefits at other companies

Twist Bioscience CorporationTWST

——

Recursion Pharmaceuticals, Inc.RXRX

——

Absci CorporationABSI

——

PrecigenPGEN

——

BridgeBio PharmaBBIO

——

Roivant SciencesROIV

——

Other financials

Income statement

See full

Revenue$8.3M+96.3%

Operating income-$57.5M+8.2%

Net income-$43.2M+5.4%

EPS (diluted)-$0.14+6.7%

Balance sheet

See full

Cash & equivalents$102.1M-44.6%

Total debt$140.2M+107%

Total equity$938.1M-8.3%

Total assets$1.3B-2.8%

Cash flow

See full

Operating cash flow-$33.5M-190%

CapEx$3.8M-64.0%

Free cash flow-$37.4M-68.3%

Valuation

See full

Market cap$1.84B+59.2%

Enterprise value$1.88B+100.0%

P/S23.3×-26.8×

Profitability

See full

Operating margin-267.6%-120pp

Net margin-181.7%-77.9pp

FCF margin-238.9%-90.9pp

Returns & leverage

See full

Return on equity-14.7%-0.8pp

Debt / equity0.1×+0.1×

Current ratio14.1×+3.9×

Where this comes from

Reported directly by AbCellera Biologics Inc. in its filing.

Tagged under the XBRL concept us-gaap:EmployeeRelatedLiabilitiesCurrent.

The official record: AbCellera Biologics Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about AbCellera Biologics Inc.'s compensation and benefits.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is AbCellera Biologics Inc.'s compensation and benefits?: AbCellera Biologics Inc. (ABCL) reported compensation and benefits of $3.93M in Q1 2026.
How has AbCellera Biologics Inc.'s compensation and benefits changed year-over-year?: AbCellera Biologics Inc.'s compensation and benefits increased by 23.2% year-over-year, from $3.19M to $3.93M.
What is the long-term trend for AbCellera Biologics Inc.'s compensation and benefits?: Over 3 years (2022 to 2025), AbCellera Biologics Inc.'s compensation and benefits has grown at a 18.6% compound annual growth rate (CAGR), from $6.45M to $10.76M.